PLGO Pelagos Insurance Capital Limit

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the reinsurance industry, including Pelagos Insurance (NYSE:PLGO) and its peers.

Pelagos Insurance Capital Ltd (NYSE:PLGO) recently announced a total dividend of $0.15 per share, with the ex-dividend date set for 2026-09-14. For investors, the ex-dividend date is the cutoff for eligibility: shareholders must own the stock before that date to receive the payment, while the paydate marks when the cash actually arrives in accounts. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.

Pelagos Insurance Capital stock reaction and recent performance Pelagos Insurance Capital (PLGO) has drawn attention after its recent share price at US$24.43 and mixed short term returns, which included a decline over the past month but a gain over the past 3 months. For investors tracking Pelagos Insurance Capital, the stock shows a 1-year total return of 45.76% and a year to date return of 26.06%. The company reports US$2,513.4 million in revenue and US$400.7 million in net income. Pelagos...

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Pelagos Insurance’s second quarter saw strong revenue growth driven by new underwriting partnerships and expansion in specialty lines such as property, marine, and asset-backed financing. However, the market responded negatively to the quarter due to a significant shortfall in non-GAAP profit versus Wall Street expectations. Management attributed the underperformance to a higher-than-normal volume of large loss events, including major claims from Middle East conflict-related incidents and a gas

Pelagos Insurance Capital Ltd (PLGO) reports 6% premium growth and 23% book value increase, while navigating a volatile quarter with a 99.5% combined ratio.

Fidelis Insurance (NYSE:FIHL), operating as Pelagos Insurance Capital, reported second-quarter operating net income of $29 million, or $0.34 per diluted common share, as higher large-loss activity pushed its quarterly combined ratio to 99.5%. For the first six months of 2026, operating net income t

Pelagos Insurance (PLGO) delivered earnings and revenue surprises of -61.36% and -3.22%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Specialty insurance provider Pelagos Insurance (NYSE:PLGO) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 10.3% year on year to $650 million. Its GAAP profit of $0.52 per share was 43% below analysts’ consensus estimates.

Specialty insurance provider Pelagos Insurance (NYSE:PLGO) will be reporting results this Wednesday after the bell. Here’s what to look for.

Oscar Health (OSCR) delivered earnings and revenue surprises of +155.81% and -0.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Horace Mann (HMN) delivered earnings and revenue surprises of +74.63% and -0.09%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Pelagos Insurance (PLGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.